Postdischarge-to-30-Day Mortality Among Patients Receiving MitraClip: A Systematic Review and Meta-Analysis
Background: MitraClip (MC) implantation is the recommended treatment for severe symptomatic mitral regurgitation in patients not responding to medical therapy and at prohibitive surgical risk. It is important to quantify immediate mortality during postdischarge-to-30-day period so as to improve the...
Main Authors: | Beni R. Verma, MD, Shashank Shekhar, MD, Toshiaki Isogai, MD, Raghuram Chava, MD, Pejman Raeisi-Giglou, DO, Agam Bansal, MD, Shameer Khubber, MD, Bryce Montane, MD, Prashansha Vaidya, MD, Simrat Kaur, MD, Manpreet Kaur, MD, Rhonda Miyasaka, MD, Serge C. Harb, MD, Amar Krishnaswamy, MD, Samir R. Kapadia, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Structural Heart |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2474870622012611 |
Similar Items
-
Successful Obliteration of a Lateral Residual Commissural Jet After MitraClip Implantation Using a Cardioform Septal Occluder
by: Sankalp P. Patel, DO, et al.
Published: (2022-11-01) -
Retrieval of Large Balloon Fragments During Transcatheter Pulmonary Valve Implantation Using a Novel Retrieval System
by: Anne C. Taylor, MD, et al.
Published: (2023-11-01) -
Tissue Heart Valve Replacement at BSMMU- Initial Experience with Two Cases
by: Rezwanul Hoque, et al.
Published: (2010-07-01) -
Transcatheter Aortic Valve Replacement in Congenital Heart Disease
by: Betemariam Sharew, MS, et al.
Published: (2024-02-01) -
How to Assess the Feasibility of a Second Transcatheter Aortic Valve Replacement When the First Valve Fails
by: Stephanie Tom, MD, et al.
Published: (2024-02-01)